Sort publications on year
-
Biometry and database analysis
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017
VERMERSCH P, SUCHET L, COLAMOARINO R, LAURENDEAU C, DETOURNAY B
Mult Scler Relat Disord ; 2020;46
-
Biometry and database analysis
Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France
POURCHER V, GOURMELEN J, BUREAU I, BOUEE S
PLOS ONE ; 2020;15(12),e0243529
-
Pharmaco - Epidemiology
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation
HANON O, VIDAL JS, PISICA-DONOSE G, ORVOËN G, DAVID JP, CHAUSSADE E, CAILLARD L, DE JONG LW, BOULLOCHE N, VINSONNEAU U, BOUEE S, KROLAK-SALMON P, FAUCHIER L, JOUANNY P, SACCO G, BELLARBRE F, BELMIN J, PUISIEUX F, LILAMAND M, PAILLAUD E, BOUREAU AS ; SAFIR STUDY GROUP
Heart ; 2020(Online)
-
Pharmaco - Epidemiology
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.
SARAUX A, COMBE B, FAGNANI F, CUKIERMAN G, BRU I, JOUBERT J.-M , SCHULLER J.-C, MASSOL J, FLIPO R.-M
Clinical and Experimental Rheumatology ; 2020(Online)
-
Pharmaco-Economics
Cost-effectiveness of emicizumab vs bypassing agents in the prevention of bleeding episodes in haemophilia A patients with anti-FVIII inhibitors in France.
POLACK B, TROSSAËRT M, COUSIN M, BAFFERT S, PRUVOT A, GODARD C.
Haemophilia ; 2020;27(1)e1-e11
-
Biometry and database analysis
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
EMERY C, TORRETON E, DEJAGER S, LEVY-BACHELOT L, BINEAU S, DETOURNAY B.
Diabetes Ther ; 2020;11(2):535-548
-
Public Health and Epidemiology
Evaluation en éducation thérapeutique.
SIMON D, DETOURNAY B.
Education Thérapeutique. Prévention et maladies chroniques Issy les Moulineaux, Elsevier Masson Ed. Collection Abrégés 4ème édition revue et augmentée ; 2020;407-420
-
Public Health and Epidemiology
Prise en charge précoce des psychoses émergentes en France. Recensement, description des activités et besoins en 2018.
LECARDEUR L, MEUNIER-CUSSAC S, GOZLAN G, DUBURCQ A, COUROUVE L, KREBS M-O.
L’Information psychiatrique ; 2020;96(7),569-576
-
Pharmaco - Epidemiology
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study
GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C.
Future Oncol ; 2020;16(16),1115-1124
-
Biometry and database analysis
Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
EMERY C, TORRETON E, BRIERE JB, THOMAS EVERS T, FAGNANI F.
J Med Econ ; 2020;23(5):513-520
-
OthersPublic Health and Epidemiology
The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report
HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.
Therapie ; 2020;52(4),420-426
-
Others
Télésurveillance et expérimentations ETAPES. Quelle pérennité après 2021 : quel modèle organisationnel et financement ?
LE DOUARIN Y, TRAVERSINO Y, GRACIET A, JOSSERAN A, ET LES PARTICIPANTS DE LA TABLE RONDE « SANTE ET ECONOMIE » DES ATELIERS DE GIENS XXXV, BRIAC BILI A, BLAISE L, CHATELLIER G, COULONJOU H, DELVAL C, DETOURNAY B, DURAND ZALESKI I, FOREST J, DAIDANI N, VANDENBERGUE J.
Therapies ; 2020;75(1),29-42
-
Public Health and Epidemiology
Exposure of adults to extremely low frequency magnetic field in France: results of the EXPERS study.
MAGNE I, SOUQUES M, COUROUVE L, DUBURCQ A, REMY E, CABANES PA.
Radioprotection ; 2020;55(1),39-50
